Search

everythinglearnresearchcommunity

for

Search:↓

Effective epilepsy management involves accurate diagnosis, understanding seizure types, identifying causes, and choosing the right treatment.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Using a fractional laser can stimulate hair growth, but the intensity and duration of inflammation are crucial. Too much can cause ulcers and scarring. Lower beam energy and fewer treatments are recommended to avoid damage.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

The microenvironment, especially mechanical forces, plays a crucial role in hair growth and could lead to new treatments for hair loss.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

The serum effectively promotes hair growth and reduces gray hair without side effects.

Follicular unit grafting is a procedure used to treat hair loss, where small hair grafts are placed into the scalp, with future treatments likely to involve smaller incisions and cell-based therapies.

The document concludes that understanding hair follicles requires more research using computational methods and an integrative approach, considering the current limitations in hair treatment products.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Baicalin may help reduce excessive male hormone levels in PCOS.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Nutrafol might help reduce hair loss due to inflammation, but more evidence is needed.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.